In a bold stride for the biotech industry, Dr. Erin E. Mauney of Tufts University and Massachusetts General Hospital is spearheading an unprecedented clinical trial which employs psilocybin, a naturally occurring psychedelic compound, in the treatment of intractable irritable bowel syndrome (IBS). This groundbreaking research, representing a pioneering shift in gastroenterology, offers a beacon of […]